Education
About Us
Working with TipRanks
Follow Us
Somnomed Limited (SOMNF)
:SOMNF
SOMNF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.12 - $0.46
Previous CloseN/A
Volume17.00K
Average Volume (3M)300.00
Market Cap
$69.21M
Enterprise Value$34.96M
Total Cash (Recent Filing)AU$8.51M
Total Debt (Recent Filing)AU$1.07M
Price to Earnings (P/E)―
Beta0.96
Next Earnings
Feb 28, 2025EPS Estimate
<0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding216,108,250
10 Day Avg. Volume0
30 Day Avg. Volume300
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.90
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$0.48Price Target Upside26.32% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
---
Somnomed Limited News
PremiumCompany Announcements
SomnoMed Addresses Impact of New US Tariffs on Operations
PremiumCompany Announcements
Somnomed Limited Reports Strong Revenue Growth
PremiumCompany Announcements
SomnoMed Limited Releases Half-Year 2025 Results
PremiumCompany Announcements
SomnoMed to Announce H1FY25 Financial Results and Host Investor Webinar
PremiumCompany Announcements
SomnoMed Limited Reports Positive Cash Flow Amidst Investment Outflows
PremiumCompany Announcements
SomnoMed Limited Updates FY25 Guidance with Strong Revenue Growth
PremiumCompany Announcements
SomnoMed Strengthens Leadership with New Director Appointment---
Options Prices
Currently, No data available
---
Ownership Overview
SOMNF FAQ
What was Somnomed Limited’s price range in the past 12 months?
Somnomed Limited lowest stock price was $0.12 and its highest was $0.46 in the past 12 months.
What is Somnomed Limited’s market cap?
Somnomed Limited’s market cap is $69.21M.
When is Somnomed Limited’s upcoming earnings report date?
Somnomed Limited’s upcoming earnings report date is Feb 28, 2025 which is 39 days ago.
How were Somnomed Limited’s earnings last quarter?
Somnomed Limited released its earnings results on Aug 27, 2024. The company reported -$0.004 earnings per share for the quarter, missing the consensus estimate of -$0.002 by -$0.002.
Is Somnomed Limited overvalued?
According to Wall Street analysts Somnomed Limited’s price is currently Undervalued.
Does Somnomed Limited pay dividends?
Somnomed Limited does not currently pay dividends.
What is Somnomed Limited’s EPS estimate?
Somnomed Limited’s EPS estimate is <0.01.
How many shares outstanding does Somnomed Limited have?
Somnomed Limited has 216,108,250 shares outstanding.
What happened to Somnomed Limited’s price movement after its last earnings report?
Somnomed Limited reported an EPS of -$0.004 in its last earnings report, missing expectations of -$0.002. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Somnomed Limited?
Currently, no hedge funds are holding shares in SOMNF
---
Somnomed Limited Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$0.48 (26.32% Upside)
$0.48 (26.32% Upside)
Insider Transactions
Bought Shares
Worth $184.2K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
78.24%
12-Months-Change
Fundamentals
Return on Equity
-15.86%
Trailing 12-Months
Asset Growth
6.46%
Trailing 12-Months
Company Description
Somnomed Limited
SomnoMed Limited, together with its subsidiaries, engages in the production and sale of devices for the oral treatment of sleep related disorders in Europe, North America, and the Asia Pacific region. It offers SomnoDent, an oral appliance for obstructive sleep apnea; SomnoBrux, a dental guard for the treatment of teeth grinding damage; SomMorning Repositioner, which help return mandible back to its pre-treatment centric position; and SomTabs for cleaning oral devices. The company was incorporated in 1987 and is headquartered in Crows Nest, Australia.
---
SOMNF Company Deck
---
SOMNF Earnings Call
Q2 2025
0:00 / 0:00
---
SOMNF Stock 12 Month Forecast
Average Price Target
$0.48
▲(26.32% Upside)
Technical Analysis
Ansell
―
Cochlear Limited
―
Fisher & Paykel Healthcare Corporation Limited
―
Ramsay Health Care
―
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
―
Best Analysts Covering SOMNF
1 Year
1 Year Success Rate
1/9 ratings generated profit
1 Year Average Return
-22.09%
reiterated a buy rating 2 months ago
Copying Shane Storey's trades and holding each position for 1 Year would result in 11.11% of your transactions generating a profit, with an average return of -22.09% per trade.
---